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Abstract 
Diabetes is a major health problem predisposing to markedly increased complications. Despite 
the numerous preventative strategies and armories of medication, the management of diabetes 
remains grossly unsatisfactory. Diabetes is emerging as a pandemic. Therefore it is important to 
identify novel nutraceuticals or drugs for curing or preventing diabetes, which have fewer side 
effects. The present paper reviewed scientific information on mushrooms with regards to its  
anti-diabetic active compounds and/or pharmacological test results, which are commonly used as 
functional  foods  and  ingredients  used  in  the  traditional  medical  system  and  which  have 
demonstrated  experimental  or/and  clinical  anti-diabetic  effectiveness.  These  functional  foods 
might have a big potential for the prevention or cure of diabetes more than in other plant species. 
However,  still  scientific  or  clinical  studies  are  not  sufficient  for  hypoglycemic  effect  for 
mushrooms use as ‗official‘ drug. Therefore, it is proposed that a close attention be paid to carry 
out further research of functional mushrooms for preventive and curative measures for diabetes 
and its complications. 
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Introduction 
As of 2000 at least 171 million people worldwide suffer from diabetes, or 2.8% of the population 
[1].  Diabetes  is  a  major  health  problem  predisposing  to  markedly  increased  cardiovascular 
mortality and serious morbidity and mortality related to development of nephropathy, neuropathy 
and  retinopathy  [2].  Although  chemical  and  biochemical  hypoglycemic  agents,  e.g.,  insulin, Functional Foods in Health and Disease 2011; 4:161-171                                                               Page 162 of 171 
tolbutamide,  phenformin,  troglitazone,  rosigitazone  and  repaglinide,  are  the  mainstay  of 
treatment of diabetes and are effective in controlling hyperglycemia, they have harmful side-
effects and fail to signiﬁcantly alter the course of diabetic complications [3].  
Some  mushrooms  appear  to  be  effective  for  both  the  control  of  blood  glucose  and  the 
modiﬁcation  of  the  course  of  diabetic  complications  without  side-effects.  This  review 
particularly  explores  the  promising  mushrooms  that  have  demonstrated  clinical  or/and 
experimental  anti-diabetic  properties  by  preventing  or  lowering  down  the  development  of 
diabetes mellitus. But still scientific or clinical studies are not sufficient enough to show the 
hypoglycemic effects of mushrooms to be use as ‗official‘ drugs or nutraceuticals. Therefore, we 
suggest a closer attention be paid to the mushrooms that have preventive and curative functions 
of diabetes mellitus and its complications. 
 
Diabetes mellitus (DM) 
There are two main types of Diabetes mellitus (DM); type I diabetes and type II diabetes. Type I 
diabetes occurs as a result of deﬁciency of insulin due to destructive lesions of pancreatic β-cells, 
and usually progresses to the stage of absolute insulin deﬁciency [4]. Typically, type I diabetes 
occurs  in  young subjects  with  acute onset, but may occur at  any age, sometimes with slow 
progression [5]. Type I diabetes may be further divided into subtypes according to the mode of 
onset (i.e. acute or slowly-progressive), HLA antigens, or epitopes of autoantigens [5, 6]. 
Most patients previously called non insulin-dependent diabetes mellitus (NIDDM) belong to 
Type II diabetes category. In this type, the mass of pancreatic β cells and their function are 
preserved to some extent, and insulin injection is seldom needed to sustain life. Ketoacidosis 
may occur in the presence of severe infection or other stress. Both decreased insulin secretion 
and decreased insulin sensitivity (insulin resistance) are involved in its pathogenesis. Insulin 
resistance may not  always be present.  The relative role of these two factors varies  between 
patients.  With  regard  to  insulin  secretion,  the  acute  insulin  response  to  a  glucose  load  is 
characteristically defective. The majority of patients are  obese or have been obese in the past. 
The prevalence of type II DM among adults varies from less than 5% to over 40% depending on 
the population in question [2]. With the increase of obesity, sedentariness and dietary habits in 
both  developed  and  developing  countries,  the  prevalence  of  type  II  DM  is  growing  at  an 
exponential  rate  [2, 7]. Typically,  type  II  DM  develops  after middle  age, but  may occur in 
younger people. Screening by urine analysis of large numbers of school children has revealed 
that type II diabetes has been steadily increasing since the 1970s [8, 9].  
 
Mushrooms as a functional food 
Chang et al. defined the mushrooms as "a macro fungus with distinctive fruiting bodies that 
could be hypogeous or epigeous, large enough to be seen by naked eyes and to be picked by 
hands [10]. From taxonomic point of view, basidiomycetes and some species of ascomycetes 
mainly belong to category of mushrooms. Mushrooms constitute 22,000 known species. They Functional Foods in Health and Disease 2011; 4:161-171                                                               Page 163 of 171 
are widely available on earth and about 10% of them are explored. Among the unexplored and 
unexamined mushrooms, if the proportion of useful mushroom is  5%, it suggests that 7000 
undiscovered species would possibly provide benefit to mankind [11]. 
Numerous species of mushrooms exist in nature; however, only a few are used as edibles. 
Many Asian countries use traditionally wild edible mushrooms as delicious and nutritional foods 
and medicine [12]. Wild edible mushrooms are appreciated not only for their texture and flavor 
but also for the chemical and nutritional characteristics [13, 14]. Edible mushrooms have higher 
protein contents and minerals and contain less fat but are rich in B vitamins, vitamin D, vitamin 
K and sometimes vitamins A and C [15-18]. Mushrooms are not only sources of nutrients but 
also have been reported as therapeutic foods, useful in preventing diseases such as hypertension, 
diabetes, hypercholesterolemia and cancer [19, 20]. These functional characteristics are mainly 
due to the presence of dietary fiber and in particular chitin and beta glucans [16]. Studies have 
also  shown  that  certain  mushrooms  species  have  antitumor,  antiviral,  antithrombotic  and 
immunomodulating  properties.  [21].  Research  has  shown  that  some  mushrooms  may  have 
potential to lower elevated blood sugar levels. But the explanation for this effect is limited, with 
the  exception  of  some  mushrooms.  Therefore  it  is  useful  to  carry  out  more  research  on 
mushrooms  with  a  view  to  identify  active  principles  in  them  for  the  treatment  of  diabetes 
mellitus and its complications. 
 
Medicinal mushrooms and diabetes 
 
Tremella fuciformis (berk) 
Tremella fuciformis has been given the common names snow fungus or silver ear fungus. In 
Chinese cuisine, Tremella fuciformis is traditionally used in sweet dishes. Despite its tasteless 
nature, T. fuciformis is valued for its gelatinous texture as well as its supposed medicinal benefits 
[22]. Glucuronoxylomannan (AC) from the fruiting bodies of T. fuciformis exhibited a significant 
dose-dependent hypoglycemic activity in normal mice and also showed a significant activity in 
streptozotocin-induced diabetic mice, by intraperitoneal administration [23].  The anti-diabetic 
activities  of  the  exopolysaccharides  (EPS)  produced  by  submerged  mycelial  culture  of  T. 
fuciformis  in  ob/ob  mice  were  investigated  [24].  The  results  suggested  that  EPS  exhibited 
considerable hypoglycemic effect and improved insulin sensitivity possibly through regulating 
PPAR-gamma-mediated lipid metabolism [24]. These results indicated that Tremella fuciformis 
has potential oral hypoglycemic effect as a functional food for the management of DM. 
 
Wolfiporia extensa (Peck) Ginns (formerly known as Poria cocos F.A. Wolf) 
Poria cocos, a rotten pine-tree fungus is a wood decay fungus but has a terrestrial growth habit. It 
has long been used as traditional Chinese medicine and food [25-27]. Poria cocos, alone or in 
combination with other herbs is often used to treat diabetes as well as other disorders [28-30]. 
Mechanistic  study  on  streptozocin  (STZ)  treated  mice  showed  that  the  crude  extract, Functional Foods in Health and Disease 2011; 4:161-171                                                               Page 164 of 171 
dehydrotumulosic acid, dehydrotrametenolic acid, and pachymic acid of Poria cocos exhibited 
different levels of insulin sensitizer activity [31]. The data suggested that the Poria cocos extract 
and its triterpenes reduce postprandial blood glucose levels in db/db mice via enhanced insulin 
sensitivity irrespective of PPAR-γ [31]. 
 
Ganoderma lucidum (Curtis) P.Karst 
Ganoderma lucidum has been use since the 4th century A.D. and is well known in China as the 
herb of longevity. Ganoderma is to be famous tonic and found an important place in Chinese 
medicine due to its beneficial effects to all viscera and nontoxic nature [32]. Research workers 
have  found  that  Ganoderma  lucidum  polysaccharides  (Gl-PS)  dose-dependently  lowered  the 
serum glucose levels after administration in mice. Ganoderma lucidum polysaccharides (Gl-PS) 
possess the hypoglycemic effect on normal mice; one mechanism is through its insulin releasing 
activity due to a facilitation of Ca2+ inflow to the pancreatic beta cells [33]. 
 
Ganoderma applanatum (Pers.) Pat. and Collybia confluens (Pers.: Fr.) Kummer 
The  hypoglycemic  effects  of  Ganoderma  applanatum  exo-polymer  (GAE)  and  Collybia 
confluens exo-polymer (CCE) produced by submerged mycelial cultures in streptozotocin (STZ)-
induced diabetic rats were shown hypoglycemic effects. The results strongly demonstrated the 
potential of GAE and CCE in combating diabetes in experimental animals [34]. 
 
Auricularia auricula-judae (Bull.)  
Auricularia  auricula-judae,  known  as  the  Jew‘s  Ear,  Jelly  Ear  is  a  species  of  edible 
Auriculariales mushroom found worldwide. Distinguished by its noticeably ear-like shape and 
brown coloration, it grows upon wood. It is popular in China, where the medicinal use of food is 
common; a soup containing A. auricula-judae, chicken, pak choi and ginger is used medicinally 
for dealing with colds and fevers by reducing the heat of the body [35]. The hypoglycemic effect 
of water-soluble polysaccharide (FA) from fruiting bodies of A. auricula-judae was investigated 
on genetically diabetic mice (KK-Ay). This study showed that FA had a hypoglycemic effect on 
KK-Ay mice, and the reduced food consumption was not a major factor which contributed to the 
hypoglycemic action of FA [36]. 
 
Agaricus campestris (L.) 
Agaricus campestris has fast maturing and short shelf-life [37]. A. campestris (mushroom) has 
been documented as a traditional treatment for diabetes. The administration of mushroom in the 
diet and drinking water countered the hyperglycaemia of streptozotocin-diabetic mice [38].  
 
Agaricus subrufescens (Peck) 
Agaricus subrufescens is a choice edible, with a somewhat sweet taste and fragrance of almonds 
[39].In Japan, A. subrufescens is also the most popular complementary and alternative medicine Functional Foods in Health and Disease 2011; 4:161-171                                                               Page 165 of 171 
used by cancer patients [40]. A. brasiliensis fruit body is useful as a health promoting food. 
Performed studies on murine models and human volunteers to examine the immune-enhancing 
effects  of  the  naturally  outdoor-cultivated  fruit  body  of  Agaricus  brasiliensis  KA21  (i.e. 
Agaricus  blazei)  has  shown  antitumor,  leukocyte-enhancing,  hepatopathy-alleviating  and 
endotoxin  shock-alleviating  effects  in  mice  [41].  In  the  human  study,  percentage  body  fat, 
percentage  visceral  fat,  blood  cholesterol  level  and  blood  glucose  level  were  decreased  and 
natural  killer  cell  activity  was  increased  [41].  Beta-glucans  and  oligosaccharides  (AO)  of 
Agaricus  blazei  Murill  showed  anti-hyperglycemic,  anti-hypertriglyceridemic,  anti-
hypercholesterolemic, and anti-arteriosclerotic activity indicating overall anti-diabetic activity in 
diabetic  rats, AO  had  about  twice  the  activity  of  beta-glucans  with  respect  to  anti-diabetic 
activity  [42].  Further  supplement  of  Agaricus  blazei  Murill  extract  has  improved  insulin 
resistance  among  subjects  with  type  2  DM.  The  increase  in  adiponectin  concentration  after 
taking Agaricus blazei Murill extract might be the mechanism that brings the beneficial effect 
[43]. 
 
Inonotus obliquus (L.) 
Chaga mushroom (Inonotus  obliquus), a white rot fungus,  belongs  to  the hymenochaetaceae 
family of Basidomycetes. Chaga mushroom grows on birch trees in colder northern climates 
[44]. Since the sixteenth century, Chaga has been used as a folk medicine in Russia and western 
Siberia  [45].  Researches  exposed  that  the  dry  matter  of  culture  broth  of  Inonotus  obliquus 
possesses  significant  anti-hyperglycemic,  anti-lipid  peroxidative  and  antioxidant  effects  in 
alloxan-induced diabetic mice [46]. 
 
Hericium erinaceus (Bull.) 
Hericium  erinaceus  is  named  for  its  shape,  and  is  literally  interpreted  as  ―Monkey  Head 
Mushroom‖  in  China.  Recent  studies  have  determined  that  many  types  of  mushroom  (eg 
Hericium spp), may have important physiological functions in humans, including antioxidant 
activities,  the  regulation  of  blood  lipid  levels  and  reduction  of  blood  glucose  levels  [47]. 
Researchers have  found that the hypoglycemic  effects  of  feeding the  methanol  extract  of  H 
erinaceus  to  streptozotocin-induced  diabetic  rats  were  significantly  lower  elevation  rates  of 
blood glucose levels [47].  
 
Agrocybe aegerita 
It is an important valuable source possessing varieties of bioactive secondary metabolites such as 
indole derivatives with free radical scavenging activity, cylindan with anticancer activity, and 
also agrocybenine with antifungal activity [48]. A glucan and a heteroglycan were isolated from 
a  hot-water  extract  of  the  fruiting  bodies  of  Agrocybe  cylindracea.  A  glucan  showed  a 
remarkable hypoglycemic activity in both normal and streptozotocin-induced diabetic mice by 
intraperitoneal administration, and its activity was higher than that of heteroglycan [49].  Functional Foods in Health and Disease 2011; 4:161-171                                                               Page 166 of 171 
 
 
Coprinus comatus (O.F.Mull)  
The young mushrooms of Coprinus comatus, before the gills start to turn black, are edible. It can 
sometimes be used in mushroom soup with parasol mushroom [50].This species is cultivated in 
China as food. When young it is an excellent edible mushroom provided that it is eaten soon 
after being collected. It can be used as a hypoglycemic food or medicine for hyperglycemic 
people [51].The hypoglycemic activity of fermented mushroom, Coprinus comatus tested on 
Alloxan and adrenalin-induced hyperglycemic mice. It confirmed that Coprinus comatus rich in 
vanadium has significant anti-hyperglycemic effect [51]. 
 
Cordyceps sinensis 
Cordyceps sinensis, known in English commonly as caterpillar fungus is considered a medicinal 
mushroom in traditional Chinese medicine [52]. Crude polysaccharides of Cordyceps sinensis 
were tested in normal mice and streptozotocin-induced diabetic mice. It significantly lowered the 
glucose level by oral administration in mice [53]. A polysaccharide obtained from the cultural 
mycelium of Cordyceps sinensis showed potent hypoglycemic activity in genetic diabetic mice 
after intraperitoneal administration, and the plasma glucose level was quickly reduced in normal 
and  streptozotocin-induced  diabetic  mice  after  intravenous  administration  [54].Further 
Cordyceps, a Chinese herbal medicine with fruiting body and carcass, has been proposed to have 
multiple medicinal activities. The diabetic rats had significantly lower weight gain and higher 
blood glucose response in oral glucose tolerance test than the control rats; and these changes 
were  significantly  reduced  by  administrating  the  fruiting  body  of  Cordyceps  and  these 
improvements suggested that fruiting body of Cordyceps has a potential to be the functional food 
for  diabetes[55].  Another  research  revealed  that  isolated  polysaccharide  from  Cordyceps 
sinensis, named CSP-1 produced a significant drop in blood glucose level in both STZ-induced 
diabetic  rats  and  alloxan-induced  diabetic  mice.  It  suggested  that  CSP-1  may  stimulate 
pancreatic release of insulin and/or reduce insulin metabolism [56]. 
  
Grifola frondosa (Dicks.) 
Grifola  frondosa  is  also  very  popular  in  Korea,  China  and  Japan,  where  it  is  cultivated  as 
maitake, the dancing mushroom. Controlled experiments have found many beneficial activities 
attributable to Grifola frondosa and/or its extracts. The reason Maitake lowers blood sugar is due 
to  the  fact  that  the  mushroom  naturally  contains  an  alpha-glucosidase  inhibitor.  Alpha-
glucosidase  inhibitory  activities  were  found  in  aqueous  methanol  extracts  of  the  seeds  of 
Momordica charantia and the fruit bodies of Grifola frondosa [57]. Researchers evaluated the 
anti-diabetic  effect  of  an  alpha-glucan  (MT-alpha-glucan)  from  the  fruit  body  of  maitake 
mushrooms (Grifola frondosa) on KK-Ay mice. These data suggest that MT-alpha-glucan has an 
anti-diabetic effect on KK-Ay mice, which might be related to its effect on insulin receptors (i.e., Functional Foods in Health and Disease 2011; 4:161-171                                                               Page 167 of 171 
increasing insulin sensitivity and ameliorating insulin resistance of peripheral target tissues) [58]. 
Further animal and human experiments also proven that anti-diabetic activity present in the fruit 
body of Grifola frondosa [59-63]. 
 
Table 1.  Medicinal mushrooms and major effective compounds 
 
Plant name  Major effective compounds 
Tremella fuciformis (berk)  Glucuronoxylomannan[23] 
Wolfiporia extensa (Peck)  Dehydrotumulosic acid, Dehydrotrametenolic 
acid and Pachymic acid [31] 
Ganoderma lucidum (Curtis)  Polysaccharides (Gl-PS) [33] 
Ganoderma applanatum (Pers.) Pat.   Exo-polymer (GAE) [34] 
Collybia confluens (Pers.: Fr.)   Exo-polymer (CCE) [34] 
Auricularia auricula-judae (Bull.)  Polysaccharide (FA) [36] 
Agaricus subrufescens (Peck)  Beta-glucans and Oligosaccharides (AO) [42] 
Coprinus comatus (O.F.Mull)   Vanadium[51] 
Cordyceps sinensis  Polysaccharide CSP-1 [56] 
Grifola frondosa (Dicks.)  Alpha-glucan (MT-alpha-glucan) [59-63] 
 
 
Conclusion 
Mushrooms with immune-modulating polysaccharides are used as delicious food or as health-
promoting  food  supplement  (nutraceutical)  or  as  drug  in  limited  geographic  regions.  But 
scientific or clinical studies are not sufficient for use as ‗official‘ drug/nutraceutical worldwide 
till now. These functional mushrooms might have a particularly high impact for prevention or 
curative of diabetes more than in other species. Therefore further research  needs to identify their 
active compounds to  develop  drug/nutraceutical use in diabetes. 
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